P3 Health Partners Inc.
PIII
$9.80
$0.717.81%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Net Income | -110.10% | -104.58% | -135.14% | 18.71% | 44.07% |
Total Depreciation and Amortization | -1.88% | -1.27% | -0.71% | -0.58% | -0.63% |
Total Amortization of Deferred Charges | -81.57% | -81.57% | -81.57% | -80.25% | -- |
Total Other Non-Cash Items | -12.21% | -19.18% | -9.36% | -112.51% | -49.78% |
Change in Net Operating Assets | 28.87% | 128.86% | 190.38% | 472.26% | 183.75% |
Cash from Operations | -141.84% | -70.82% | -44.85% | 25.34% | 49.06% |
Capital Expenditure | -- | -- | -- | 110.66% | 92.95% |
Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
Cash Acquisitions | -- | -- | -- | -- | -- |
Divestitures | -- | -- | -- | -- | -- |
Other Investing Activities | -- | -- | -- | -- | -- |
Cash from Investing | 8,428.57% | 1,165.66% | 895.02% | 864.81% | 97.81% |
Total Debt Issued | 306.38% | 819.92% | 537.74% | -7.66% | -7.67% |
Total Debt Repaid | -2,843.75% | -7,082.33% | -- | -- | 11.79% |
Issuance of Common Stock | -99.94% | -51.63% | -51.57% | -51.60% | -51.60% |
Repurchase of Common Stock | -106.57% | -117.74% | -148.67% | -2,816.47% | -- |
Issuance of Preferred Stock | -- | -- | -- | -- | -- |
Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
Total Dividends Paid | -- | -- | -- | -- | -- |
Other Financing Activities | 46.67% | -115.23% | -75.29% | -352.02% | -264.16% |
Cash from Financing | 14.85% | 20.89% | -1.56% | -44.73% | -42.11% |
Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
Net Change in Cash | -406.03% | -62.44% | -85.91% | -51.73% | 693.94% |